Panacea Biotec touches the roof on inking strategic pact with Osmotica Pharmaceutical

11 Sep 2012 Evaluate

Panacea Biotec is currently trading at its upper circuit limit of Rs. 107.25, up by 17.85 points or 19.97 % from its previous closing of Rs. 89.40 on the BSE.

The scrip opened at Rs. 92.00 and has touched a high and low of Rs. 107.25 and Rs. 91.00 respectively. So far 133920 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 145.95 on 13-Sep-2011 and a 52 week low of Rs. 63.50 on 04-Jun-2012.

Last one week high and low of the scrip stood at Rs. 107.25 and Rs. 73.00 respectively. The current market cap of the company is Rs. 656.91 crore.

The promoters holding in the company stood at 74.81 % while Institutions and Non-Institutions held 2.99 % and 22.20 % respectively. 

Panacea Biotec, India’s highly progressive research based health management company has entered into a strategic alliance for the research, development and commercialization of drug delivery based, high barrier to entry generic and branded pharmaceutical products in US and key strategic  markets across the globe, with Osmotica Pharmaceutical, a global pharmaceutical company specializing in drug delivery technologies. The collaboration is designed to build upon each company’s highly complementary strengths and quality assets.

Under the collaboration, Panacea Biotec would lead product identification, research, development and manufacturing while Osmotica would lead registration, legal matters, marketing, sales and distribution. The collaboration products are expected to be sold under an Osmotica and Panacea Biotec label.

This collaboration is based on a 50:50 risk, investment and profit sharing by both companies and starts with a portfolio of 18 products across a broad range of therapeutic categories, with a provision to add new products by the joint steering committee represented by both Osmotica and Panacea Biotec. According to the agreement, Panacea Biotec will receive initial research fee from Osmotica.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

407.05 48.55 (13.54%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×